Product Introduction
Febuxostat is a non-purine xanthine oxidase inhibitor prescribed for managing hyperuricemia. This powder-form compound effectively lowers blood uric acid levels in patients with hyperuricemia (gout), primarily undergoing hepatic metabolism and independent of renal clearance.
Product Data Sheet
| Product name | Febuxostat tablet | Purity | 99% |
| CAS No. | 144060-53-7 | Molecular Formula | C16H16N2O3S |
| Melting Point | 238-239°(dec.) | Boiling Point | 536.6±60.0 °C(Predicted) |
| Density | 1.31±0.1 g/cm3(Predicted) | Storage Temperature | 2-8°C |
| Solubility | DMSO (Slightly), Methanol (Slightly) | Acidity Coefficient (pKa) | 2.48±0.10(Predicted) |
Product Function & Usage
- Designed for the prolonged management of symptomatic hyperuricemia in gout patients.
- Recommended oral dosages: 20mg, 40mg, and 80mg.
Packaging & Delivery
FAQ
Q1: Is it safe for personal use?
A: We recommend consulting a healthcare professional before taking Febuxostat.
Q2: Do you provide a free sample?
A: For sample availability and terms, please contact our support team.
Q3: What payment methods do you accept?
A: Multiple options are available, including Pingpong, TT, PayPal, Western Union, L/C, and more—select your preferred method at checkout.
Q4: When will I receive my order after payment?
A: Delivery times vary based on order size and shipping method. Our sales team will provide detailed timelines.
For further questions regarding Febuxostat, feel free to reach out.
E-mail: [email protected]
